David J. Gregory

Rhode Island Hospital — United States

Medicine · Health Sciences

24h-index5.3kcitations52works4.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(14), Research on Leishmaniasis Studies(11), Epigenetics and DNA Methylation(7), Viral gastroenteritis research and epidemiology(7), COVID-19 Clinical Research Studies(6)

Publications52 total

Vector-free intra-airway in vivo epigenetic editing
Trends in biotechnology·2025· 1 citedOpen Access
Molecular profiles of blood from numerous species that differ in sensitivity to acute inflammation
Molecular Medicine·2024· 6 citedOpen Access
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
Cell Reports Medicine·2024· 13 citedOpen Access
Phase I trial MM-120-102
http://isrctn.com/·2024
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
2024· 3 citedOpen Access
Multi-Omic blood analysis reveals differences in innate inflammatory sensitivity between species
2023· 3 citedOpen Access
Macrophage metallothioneins participate in the antileishmanial activity of antimonials
Frontiers in Parasitology·2023· 3 citedOpen Access
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19
Virulence·2022· 37 citedOpen Access
Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series and Additional Dose Vaccine in Patients With Predominant Antibody Deficiency
The Journal of Allergy and Clinical Immunology In Practice·2022· 22 citedOpen Access
Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine
The Journal of Infectious Diseases·2022· 2 citedOpen Access
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Cell·2022· 1.1k citedOpen Access
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19
Figshare·2022Open Access
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
2021· 123 citedOpen Access
Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines
The Journal of Infectious Diseases·2021· 130 citedOpen Access
Abstract 13066: Circulating Cellular Clusters: A Proposed Mechanism and Novel Biomarker for Immunothrombosis and Clinical Outcomes in Patients With COVID-19
Circulation·2021
Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines
2021· 35 citedOpen Access
Consideration on Efficient Recombinant Protein Production: Focus on Substrate Protein-Specific Compatibility Patterns of Molecular Chaperones
The Protein Journal·2021· 6 citedOpen Access
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Cell·2021· 325 citedOpen Access
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Cell·2021· 1.5k citedOpen Access
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
2021· 214 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Mark C. Poznansky(13), Wilfredo F. García-Beltrán(11), Evan C. Lam(11), Kerri St. Denis(11), A. John Iafrate(11), Alejandro B. Balazs(11), Lester Kobzik(11), Vivek Naranbhai(10), Alexey V. Fedulov(7), Adam D. Nitido(6), Blake M. Hauser(6), Jared Feldman(6), Maia Pavlovic(6), Aaron G. Schmidt(6), Martin Olivier(6), Maegan L. Sheehan(5), Christina C. Chang(5), Igor Kramnik(5), Cristhian Berrios(4), Onosereme Ofoman(4)